IL160029A0 - Receptor, the use thereof, and mouse antibodies - Google Patents

Receptor, the use thereof, and mouse antibodies

Info

Publication number
IL160029A0
IL160029A0 IL16002902A IL16002902A IL160029A0 IL 160029 A0 IL160029 A0 IL 160029A0 IL 16002902 A IL16002902 A IL 16002902A IL 16002902 A IL16002902 A IL 16002902A IL 160029 A0 IL160029 A0 IL 160029A0
Authority
IL
Israel
Prior art keywords
receptor
determinant
mouse antibodies
murine antibody
antibody
Prior art date
Application number
IL16002902A
Other languages
English (en)
Inventor
Hans-Konrad Muller-Hermelink
Heinz Vollmers
Frank Hensel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2001136009 external-priority patent/DE10136009A1/de
Priority claimed from DE2002110425 external-priority patent/DE10210425A1/de
Application filed filed Critical
Publication of IL160029A0 publication Critical patent/IL160029A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL16002902A 2001-07-24 2002-07-23 Receptor, the use thereof, and mouse antibodies IL160029A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2001136009 DE10136009A1 (de) 2001-07-24 2001-07-24 Rezeptor, dessen Verwendung sowie Mausantikörper
DE2002110425 DE10210425A1 (de) 2002-03-09 2002-03-09 Rezeptor, dessen Verwendung sowie Mausantikörper
PCT/DE2002/002699 WO2003011907A2 (de) 2001-07-24 2002-07-23 Rezeptor, dessen verwendung sowie mausantikörper

Publications (1)

Publication Number Publication Date
IL160029A0 true IL160029A0 (en) 2004-06-20

Family

ID=26009767

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16002902A IL160029A0 (en) 2001-07-24 2002-07-23 Receptor, the use thereof, and mouse antibodies
IL160029A IL160029A (en) 2001-07-24 2004-01-23 Purified polypeptides that bind a human adenocarcinoma cell line

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL160029A IL160029A (en) 2001-07-24 2004-01-23 Purified polypeptides that bind a human adenocarcinoma cell line

Country Status (11)

Country Link
US (2) US7378247B2 (zh)
EP (2) EP1423425B1 (zh)
JP (1) JP4344237B2 (zh)
CN (2) CN101812133A (zh)
AT (1) ATE490271T1 (zh)
AU (1) AU2002325164B2 (zh)
CA (1) CA2455154A1 (zh)
DE (1) DE50214797D1 (zh)
IL (2) IL160029A0 (zh)
RU (1) RU2004105599A (zh)
WO (1) WO2003011907A2 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1423425B1 (de) 2001-07-24 2010-12-01 Debiovision Inc. Rezeptor, dessen verwendung sowie mausantikörper
CA2491669A1 (en) 2002-07-04 2004-01-15 Oncomab Gmbh Neoplasm specific antibodies and uses thereof
DE10311248A1 (de) 2003-03-14 2004-09-30 Müller-Hermelink, Hans Konrad, Prof. Dr. Humaner monoklonaler Antikörper
EP1531162A1 (en) 2003-11-14 2005-05-18 Heinz Vollmers Adenocarcinoma specific antibody SAM-6, and uses thereof
DE10353175A1 (de) 2003-11-14 2005-06-16 Müller-Hermelink, Hans Konrad, Prof. Dr. Humaner monoklonaler Antikörper mit fettsenkender Wirkung
US20090029460A1 (en) * 2004-01-26 2009-01-29 Peter Vollmers Neoplasm-specific polypeptides and their uses
JP2008506352A (ja) * 2004-01-26 2008-03-06 デビオビジョン・インコーポレーテッド 新生物特異的ポリペプチド及びその使用
DE102004015179A1 (de) * 2004-03-25 2005-10-13 Oncomab Gmbh Antigen des PM-2 Antikörpers und dessen Verwendung
US8901276B2 (en) 2010-12-20 2014-12-02 The Regents Of The University Of Michigan Peptide reagents and methods for detection of colon dysplasia

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
US5618920A (en) * 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
US6020145A (en) * 1989-06-30 2000-02-01 Bristol-Myers Squibb Company Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96
GB9323648D0 (en) * 1992-11-23 1994-01-05 Zeneca Ltd Proteins
JP2002501484A (ja) * 1997-03-05 2002-01-15 アメリカ合衆国 免疫毒素および免疫寛容を誘導する方法
ATE264873T1 (de) 1998-12-22 2004-05-15 Heinz Peter Vollmers Fragment des glycoproteins cd55/daf zur gewinnung hochwirksamer tumorarzneien sowie verfahren zu dessen verwendung
EP1423425B1 (de) * 2001-07-24 2010-12-01 Debiovision Inc. Rezeptor, dessen verwendung sowie mausantikörper
DE10210427A1 (de) 2002-03-09 2003-10-09 Hans Konrad Mueller-Hermelink Humaner monoklonaler Antikörper
CA2491669A1 (en) 2002-07-04 2004-01-15 Oncomab Gmbh Neoplasm specific antibodies and uses thereof

Also Published As

Publication number Publication date
ATE490271T1 (de) 2010-12-15
US7378247B2 (en) 2008-05-27
JP4344237B2 (ja) 2009-10-14
CA2455154A1 (en) 2003-02-13
US20050032134A1 (en) 2005-02-10
DE50214797D1 (de) 2011-01-13
EP1423425B1 (de) 2010-12-01
CN101812133A (zh) 2010-08-25
IL160029A (en) 2010-04-15
JP2005508884A (ja) 2005-04-07
EP2348045A1 (de) 2011-07-27
AU2002325164B2 (en) 2008-12-04
WO2003011907A3 (de) 2003-10-16
RU2004105599A (ru) 2005-07-27
WO2003011907A2 (de) 2003-02-13
US20090136420A1 (en) 2009-05-28
EP1423425A2 (de) 2004-06-02
CN1558914A (zh) 2004-12-29

Similar Documents

Publication Publication Date Title
DK1531850T3 (da) Anvendelse af 1L-21 og monoklonalt antistof til behandling af solide cancere
ATE403680T1 (de) Herstellung tetravalenter antikörper
ATE226641T1 (de) Humaner 4-1bb spezifischer humaner antikörper und diesen produzierende zellinie
DK0626447T3 (da) Monoklonale antistoffer og Fv, som er specifikke for CD2-antigen
EP1329459A3 (en) Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
AU3327701A (en) Humanized anti-ccr2 antibodies and methods of use therefor
UA41888C2 (uk) Злитий білок, який складається з мишачого або олюдненого моноклонального антитіла мав425 або його фрагменту, який спрямовано проти пухлинної клітини, спосіб його отримання, фармацевтична композиція
MXPA03005273A (es) Anticuerpos producidos procarioticamente y sus usos.
HUP0402192A2 (hu) EGF receptor elleni antitesteket tartalmazó liofilizált készítmény
WO1999062526A3 (en) Use of genetically engineered antibodies to cd38 to treat multiple myeloma
AU1986588A (en) Growth hormone receptor
WO2001068708A3 (en) Human and humanized fap-alpha-specific antibodies
AU5055593A (en) Antibodies specific for HIV
DK388384D0 (da) Monoklone antistoffer med specifitet for membran-associerede antigene, deres fremstilling og anvendelse
IL160029A0 (en) Receptor, the use thereof, and mouse antibodies
CA2068222A1 (en) Monoclonal antibodies
IL144265A0 (en) Use of antibodies for the vaccination against cancer
PT1331944E (pt) Utilização de anticorpos monoclonais específicos para cd28 para a estimulação de células sanguíneas que não comportam qualquer cd28
IL139852A0 (en) Monoclonal antibodies directed against the g3bp protein, and uses
GB0219524D0 (en) Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor
EP0990703A4 (en) NEW POLYPEPTIDE, FOR CODING DNA AND THEIR USE
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
AR010333A1 (es) Una muteina ob, una secuencia de adn, un vector de expresion una celula hospedadora procariota o de mamifero, un baculovirus recombinante, una celulahospedadora, un metodo para la produccion de una muteina ob, una composicion farmaceutica, el uso de una proteina ob para la preparacion de una composi
WO2005049635A3 (de) Humaner monoklonaler antikörper mit fettsenkender wirkung
DK0672685T3 (da) Monoklonalt antistof specifik for tumor cytotoxisk faktor (TCF-11)